Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands

BACKGROUND: Procalcitonin (PCT) testing can help in safely reducing antibiotic treatment duration in intensive care patients with sepsis. However, the cost-effectiveness of such PCT guidance is not yet known. METHODS: A trial-based analysis was performed to estimate the cost-effectiveness of PCT gui...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Crit Care
Auteurs principaux: Kip, Michelle M. A., van Oers, Jos A., Shajiei, Arezoo, Beishuizen, Albertus, Berghuis, A. M. Sofie, Girbes, Armand R., de Jong, Evelien, de Lange, Dylan W., Nijsten, Maarten W. N., IJzerman, Maarten J., Koffijberg, Hendrik, Kusters, Ron
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2018
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6234639/
https://ncbi.nlm.nih.gov/pubmed/30424796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-018-2234-3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires